Dudediligence.

Lexeo Therapeutics, Inc

LXEONASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$29.5MSep ’24−$25.9MDec ’24−$32.7MMar ’25−$26.1MJun ’25−$20.3MSep ’25−$21.0MDec ’25−$20.2MMar ’26−$25.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$654,000none on filenone on filenone on file
Operating incomenone on file−$60.5M−$68.5M−$105.8M−$109.3M
Net incomenone on file−$59.3M−$66.4M−$98.3M−$100.0M
Operating cash flownone on file−$54.6M−$59.5M−$81.2M−$98.6M
Free cash flownone on file−$55.2M−$59.6M−$81.6M−$99.0M
Cash$135.9M$77.3M$121.5M$35.0M$63.0M
Shares outstandingnone on file1.6M26.6M33.1M73.0M